Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae

被引：2
|
作者：
Rup, Amit Ranjan [1 ]
Dash, Arun Kumar [1 ]
Patnaik, Sibabratta [1 ]
机构：
[1] Kalinga Inst Med Sci, Dept Pediat, Bhubaneswar 751024, Odisha, India
来源：
INDIAN JOURNAL OF PEDIATRICS | 2021年 / 88卷 / 03期
关键词：
D O I：
10.1007/s12098-020-03546-y
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：290 / 291
页数：2
相关论文
共 50 条
  • [31] Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
    Deshpande, Devyani
    Srivastava, Shashikant
    Chapagain, Moti
    Magombedze, Gesham
    Martin, Katherine R.
    Cirrincione, Kayle N.
    Lee, Pooi S.
    Koeuth, Thearith
    Dheda, Keertan
    Gumbo, Tawanda
    SCIENCE ADVANCES, 2017, 3 (08):
  • [32] Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
    Humphries, Romney M.
    Hemarajata, Peera
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [33] Pneumonia Due to Drug-Resistant Streptococcus pneumoniae
    Jinno, Sadao
    Jacobs, Michael R.
    CURRENT INFECTIOUS DISEASE REPORTS, 2012, 14 (03) : 292 - 299
  • [34] Pneumonia Due to Drug-Resistant Streptococcus pneumoniae
    Sadao Jinno
    Michael R. Jacobs
    Current Infectious Disease Reports, 2012, 14 : 292 - 299
  • [35] In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/ aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
    Borde, Kalyani
    Kareem, M. A.
    Sharma, Ratna Mani
    Dass, S. Manick
    Ravi, Vedantham
    Mathai, Dilip
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [36] Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant Klebsiella pneumonia
    Mantzarlis, Konstantinos
    Manoulakas, Efstratios
    Parisi, Kyriaki
    Sdroulia, Evaggelia
    Zapaniotis, Nikolaos
    Tsolaki, Vassiliki
    Zakynthinos, Epaminondas
    Makris, Demosthenes
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [37] KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae
    Findlay, Jacqueline
    Poirel, Laurent
    Juhas, Mario
    Nordmann, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [38] Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates
    Carattoli, Alessandra
    Arcari, Gabriele
    Bibbolino, Giulia
    Sacco, Federica
    Tomolillo, Dario
    Di Lella, Federica Maria
    Trancassini, Maria
    Faino, Luigi
    Venditti, Mario
    Antonelli, Guido
    Raponi, Giammarco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [39] Successful Treatment of Pandrug-resistant Klebsiella pneumoniae Infection With Ceftazidime-avibactam in a Preterm Infant A Case Report
    Coskun, Yesim
    Atici, Serkan
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : 854 - 856
  • [40] Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice
    Eren-Kutsoylu, Oya Ozlem
    Ceylan-Cimendag, Hacer
    Sari-Kaygisiz, Ayse Nur
    Tanriverdi, Elif Seren
    Ozbek, Ozgen Alpay
    Oktem, Ibrahim Mehmet Ali
    Otlu, Baris
    Avkan-Oguz, Vildan
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (07): : 1020 - 1025
12345